KNW צמיחת רווח נקי למניה משנה לשנה ב-12 החודשים האחרונים Know Labs Corporation

Know Labs, Inc. (KNW) is developing a painless radio-frequency-based glucose sensor that eliminates the need for skin punctures. The quarterly EPS growth history demonstrates capital dynamics, where the 72.80 metric serves as the target level. The development of Bio-RFID relies on partnerships with medical centers, while the active calibration of AI algorithms prepares prototypes for final FDA certification.

The development of non-invasive radiofrequency glucose analysis with robust patent protection lays the foundation for future ultra-high margins and free cash flow inflows for Know Labs, Inc. (KNW). The quarterly EPS growth rate reflects the dynamics of net income per share, allowing investors to assess the real efficiency of the business and avoid emotional overpayment during sharp fluctuations in the asset's market value.